| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/(SICI)1099-081X(199708)18:6<509::AID-BDD38>3.0.CO;2-5 |
| P698 | PubMed publication ID | 9267683 |
| P2093 | author name string | J S Grundy | |
| R T Foster | |||
| L A Eliot | |||
| P433 | issue | 6 | |
| P921 | main subject | nifedipine | Q39111 |
| P304 | page(s) | 509-522 | |
| P577 | publication date | 1997-08-01 | |
| P1433 | published in | Biopharmaceutics and Drug Disposition | Q15766879 |
| P1476 | title | Extrahepatic first-pass metabolism of nifedipine in the rat | |
| P478 | volume | 18 |
| Q40359652 | A physiologically based pharmacokinetic model to predict the pharmacokinetics of highly protein-bound drugs and the impact of errors in plasma protein binding |
| Q37104008 | An intestinal epithelium-specific cytochrome P450 (P450) reductase-knockout mouse model: direct evidence for a role of intestinal p450s in first-pass clearance of oral nifedipine |
| Q37534607 | Contribution of baicalin on the plasma protein binding displacement and CYP3A activity inhibition to the pharmacokinetic changes of nifedipine in rats in vivo and in vitro. |
| Q84415824 | Contribution of rat intestinal metabolism to the xenobiotics clearance |
| Q35045446 | Despite increased plasma concentration, inflammation reduces potency of calcium channel antagonists due to lower binding to the rat heart |
| Q74663308 | Effects of hyperlipidemia on the pharmacokinetics of nifedipine in the rat |
| Q41828997 | Pharmacokinetics of dietary cancer chemopreventive compound dibenzoylmethane in rats and the impact of nanoemulsion and genetic knockout of Nrf2 on its disposition |
Search more.